National Cancer Institute; Notice of Closed Meetings, 64848-64850 [2018-27178]

Download as PDF 64848 Federal Register / Vol. 83, No. 242 / Tuesday, December 18, 2018 / Notices TOTAL ESTIMATED ANNUALIZED BURDEN HOURS Number of respondents Form name Number of responses per respondent Average burden per response (in hours) Total responses Total burden hours Form 4: Section A—Quarterly Performance Report—State/ Territory Awardees ........................................................... Form 4: Section B—Quarterly Benchmark Performance Measures .......................................................................... 56 4 224 24 5,376 1 10 4 40 200 8,000 Total .............................................................................. 2 56 ........................ 264 ........................ 13,376 Amy P. McNulty, Acting Director, Division of the Executive Secretariat. Sherrette Funn, Sherrette.Funn@hhs.gov or (202) 795–7714. When submitting comments or requesting information, please include the document identifier 0990–New–30D and project title for reference. [FR Doc. 2018–27348 Filed 12–17–18; 8:45 am] BILLING CODE 4165–15–P DEPARTMENT OF HEALTH AND HUMAN SERVICES Interested persons are invited to send comments regarding this burden estimate or any other aspect of this collection of information, including any of the following subjects: (1) The necessity and utility of the proposed information collection for the proper performance of the agency’s functions; (2) the accuracy of the estimated burden; (3) ways to enhance the quality, utility, and clarity of the information to be collected; and (4) the use of automated collection techniques or other forms of information technology to minimize the information collection burden. Title of the Collection: HHS 42 CFR subpart B; Sterilization of Persons in Federally Assisted Family Planning Projects. Type of Collection: Extension. OMB No.: 0937–0166. SUPPLEMENTARY INFORMATION: [Document Identifier: OS–0990–New] Agency Information Collection Request. 30-Day Public Comment Request Office of the Secretary, HHS. Notice. AGENCY: ACTION: Abstract: This is a request for extension of a currently approved collection for the disclosure and recordkeeping requirements codified at 42 CFR part 50, subpart B (‘‘Sterilization of Persons in Federally Assisted Family Planning Projects’’). The consent form solicits information to assure voluntary and informed consent to persons undergoing sterilization in programs of health services which are supported by federal financial assistance administered by the PHS. It provides additional procedural protection to the individual and the regulation requires that the consent form be a copy of the form that is appended to the PHS regulation. In 2003, the PHS sterilization consent form was revised to conform to OMB government-wide standards for the collection of race/ ethnicity data and to incorporate the PRA burden statement as part of the consent form. We are requesting a three year extension. Type of respondent: Individuals seeking sterilization; frequency: Once; prior to procedure. FOR FURTHER INFORMATION CONTACT: In compliance with the requirement of the Paperwork Reduction Act of 1995, the Office of the Secretary (OS), Department of Health and Human Services, is publishing the following summary of a proposed collection for public comment. DATES: Comments on the ICR must be received on or before January 17, 2019. ADDRESSES: Submit your comments to OIRA_submission@omb.eop.gov or via facsimile to (202) 395–5806. SUMMARY: ESTIMATED ANNUALIZED BURDEN TABLE Number of respondents amozie on DSK3GDR082PROD with NOTICES Type of respondent Number responses per respondent Average burden per response (in hours) Total burden hours Citizens Seeking Sterilization .......................................................................... Citizens Seeking Sterilization .......................................................................... 100,000 100,000 1 1 1 15/60 100,000 25,000 Total .......................................................................................................... ........................ 2 ........................ 125,000 Terry Clark, Asst. Paperwork Reduction Act Reports Clearance Officer, Office of the Secretary. DEPARTMENT OF HEALTH AND HUMAN SERVICES [FR Doc. 2018–27366 Filed 12–17–18; 8:45 am] National Institutes of Health BILLING CODE 4150–34–P National Cancer Institute; Notice of Closed Meetings Pursuant to section 10(d) of the Federal Advisory Committee Act, as amended, notice is hereby given of the following meetings. VerDate Sep<11>2014 00:45 Dec 18, 2018 Jkt 247001 PO 00000 Frm 00040 Fmt 4703 Sfmt 4703 The meetings will be closed to the public in accordance with the provisions set forth in sections 552b(c)(4) and 552b(c)(6), Title 5 U.S.C., as amended. The grant applications and/or contract proposals and the discussions could disclose confidential trade secrets or commercial property such as patentable material, and personal information concerning individuals associated with grant and/or contract proposals applications, the E:\FR\FM\18DEN1.SGM 18DEN1 Federal Register / Vol. 83, No. 242 / Tuesday, December 18, 2018 / Notices amozie on DSK3GDR082PROD with NOTICES disclosure of which would constitute a clearly unwarranted invasion of personal privacy. Name of Committee: National Cancer Institute Special Emphasis Panel; Improving the Reach and Quality of Cancer Care in Rural Populations Date: January 18, 2019. Time: 7:30 a.m. to 5:00 p.m. Agenda: To review and evaluate grant applications. Place: Bethesda North Marriott Hotel & Conference Center, 5701 Marinelli Road, North Bethesda, MD 20852. Contact Person: Clifford W. Schweinfest, Ph.D., Scientific Review Officer, Special Review Branch Division of Extramural Activities, National Cancer Institute, NIH, 9609 Medical Center Drive, Room 7W108 Bethesda, MD 20892–9750, 240–276–6343, schweinfestcw@mail.nih.gov. Name of Committee: National Cancer Institute, Special Emphasis Panel; NCI SPORE II (P50). Date: January 29–30, 2019. Time: 8:30 a.m. to 5:00 p.m. Agenda: To review and evaluate grant applications. Place: Gaithersburg Marriott Washingtonian Center, 9751 Washingtonian Boulevard, Gaithersburg, MD 20878. Contact Person: Wlodek Lopaczynski, M.D., Ph.D., Scientific Review Officer, Office of the Director, Division of Extramural Activities, National Cancer Institute, NIH 9609 Medical Center Drive, Room 7W514, Bethesda, MD 20892–9750 240–276–6340, lopacw@mail.nih.gov. Name of Committee: National Cancer Institute Special Emphasis Panel; SEP–5: NCI Clinical and Translational R21 and Omnibus R03. Date: February 1, 2019. Time: 8:00 a.m. to 5:00 p.m. Agenda: To review and evaluate grant applications. Place: Hyatt Regency Bethesda, One Bethesda Metro Center, 7400 Wisconsin Avenue Bethesda, MD 20814. Contact Person: Robert S. Coyne, Ph.D., Scientific Review Officer, Special Review Branch, Division of Extramural Activities, National Cancer Institute, NIH, 9609 Medical Center Drive, Room 7W236, Bethesda, MD 20892–9750 240–276–5120, coyners@mail.nih.gov. Name of Committee: National Cancer Institute, Special Emphasis Panel; Quantitative Imaging Tools and Methods for Cancer Therapy Response Assessment. Date: February 1, 2019. Time: 11:00 a.m. to 3:30 p.m. Agenda: To review and evaluate grant applications. Place: National Cancer Institute, Shady Grove, 9609 Medical Center Drive, Room 7W640, Rockville, MD 20850 (Telephone Conference Call). Contact Person: Saejeong J. Kim, Ph.D., Scientific Review Officer, Special Review Branch, Division of Extramural Activities, National Cancer Institute, NIH, 9609 Medical Center Drive, Room 7W640, Bethesda, MD 20892–9750, 240–276–5179, saejeong.kim@nih.gov. VerDate Sep<11>2014 00:45 Dec 18, 2018 Jkt 247001 Name of Committee: National Cancer Institute Special Emphasis Panel; SEP–3: NCI Clinical and Translational R21 and Omnibus R03. Date: February 7–8, 2019. Time: 4:00 p.m. to 5:00 p.m. Agenda: To review and evaluate grant applications. Place: Bethesda North Marriott Hotel & Conference Center, 5701 Marinelli Road, North Bethesda, MD 20852. Contact Person: Ombretta Salvucci, Ph.D., Scientific Review Officer, Special Review Branch, Division of Extramural Activities, National Cancer Institute, NIH, 9609 Medical Center Drive, Room 7W264, Bethesda, MD 20892–9750, 240–276–7286, salvucco@mail.nih.gov. Name of Committee: National Cancer Institute Special Emphasis Panel; TEP–3: SBIR Contract Review. Date: February 13–14, 2019. Time: 10:00 a.m. to 2:00 p.m. Agenda: To review and evaluate contract proposals. Place: National Cancer Institute, Shady Grove, 9609 Medical Center Drive, Room 2W032, Rockville, MD 20850 (Telephone Conference Call). Contact Person: Eduardo E. Chufan, Ph.D., Scientific Review Officer, Research Technology and Contract Review Branch, Division of Extramural Activities, National Cancer Institute, NIH, 9609 Medical Center Drive, Room 7W254, Bethesda, MD 20892– 9750, 240–276–7975, chufanee@mail.nih.gov. Name of Committee: National Cancer Institute Special Emphasis Panel; Biological Comparisons in Patient-Derived Models of Cancer. Date: February 22, 2019. Time: 1:00 p.m. to 3:00 p.m. Agenda: To review and evaluate grant applications. Place: National Cancer Institute, Shady Grove, 9609 Medical Center Drive, Room 7W236, Rockville, MD 20850 (Telephone Conference Call). Contact Person: Robert S. Coyne, Ph.D., Scientific Review Officer, Special Review Branch, Division of Extramural Activities, National Cancer Institute, NIH, 9609 Medical Center Drive, Room 7W236, Bethesda, MD 20892–9750, 240–276–5120, coyners@mail.nih.gov. Name of Committee: National Cancer Institute Special Emphasis Panel; SEP–7: NCI Clinical and Translational R21 and Omnibus R03. Date: February 28, 2019. Time: 7:30 a.m. to 5:00 p.m. Agenda: To review and evaluate grant applications. Place: Bethesda North Marriott Hotel & Conference Center, 5701 Marinelli Road, North Bethesda, MD 20852. Contact Person: Saejeong J. Kim, Ph.D., Scientific Review Officer, Special Review Branch, Division of Extramural Activities, National Cancer Institute, NIH, 9609 Medical Center Drive, Room 7W640, Bethesda, MD 20892–9750, 240–276–2432, saejeong.kim@nih.gov. Name of Committee: National Cancer Institute Special Emphasis Panel; NCORP Research Bases. PO 00000 Frm 00041 Fmt 4703 Sfmt 4703 64849 Date: March 5, 2019. Time: 8:00 a.m. to 5:00 p.m. Agenda: To review and evaluate grant applications. Place: National Cancer Institute, Shady Grove, 9609 Medical Center Drive, Room 7W032/034, Rockville, MD 20850. Contact Person: Michael B. Small, Ph.D., Scientific Review Officer, Program and Review Extramural Staff Training Office, Division of Extramural Activities, National Cancer Institute, NIH, 9609 Medical Center Drive, Room 7W412, Bethesda, MD 20892– 9750, 240–276–6384, smallm@mail.nih.gov. Name of Committee: National Cancer Institute Special Emphasis Panel; Community Oncology Research Program— Community Sites. Date: March 7–8, 2019. Time: 8:00 a.m. to 5:00 p.m. Agenda: To review and evaluate grant applications. Place: National Cancer Institute, Shady Grove, 9609 Medical Center Drive, Room TE406, Rockville, MD 20850. Contact Person: Timothy C. Meeker, M.D., Ph.D., Scientific Review Officer, Resources and Training Review Branch, Division of Extramural Activities, National Cancer Institute, NIH, 9609 Medical Center Drive, Room 7W606, Bethesda, MD 20892–9750, 240–276–6464, meekert@mail.nih.gov. Name of Committee: National Cancer Institute Special Emphasis Panel; SEP–1 for Provocative Questions. Date: March 7, 2019. Time: 8:00 a.m. to 5:00 p.m. Agenda: To review and evaluate grant applications. Place: Bethesda North Marriott Hotel & Conference Center, 5701 Marinelli Road, North Bethesda, MD 20852. Contact Person: Hasan Siddiqui, Ph.D. , Scientific Review Officer, Special Review Branch, Division of Extramural Activities, National Cancer Institute, NIH, 9609 Medical Center Drive, Room 7W240, Bethesda, MD 20892–9750, 240–276–5122, hasan.siddiqui@nih.gov. Name of Committee: National Cancer Institute Special Emphasis Panel; SEP–6: NCI Clinical and Translational R21 and Omnibus R03. Date: March 7–8, 2019. Time: 5:00 p.m. to 4:00 p.m. Agenda: To review and evaluate grant applications. Place: Bethesda North Marriott Hotel & Conference Center, 5701 Marinelli Road, North Bethesda, MD 20852. Contact Person: Eduardo E. Chufan, Ph.D., Scientific Review Officer, Research Technology and Contract Review Branch, Division of Extramural Activities, National Cancer Institute, NIH, 9609 Medical Center Drive, Room 7W254, Bethesda, MD 20892– 9750, 240–276–7975, chufanee@mail.nih.gov. Name of Committee: National Cancer Institute Special Emphasis Panel SEP–4 for Provocative Questions. Date: March 14–15, 2019. Time: 6:00 p.m. to 3:00 p.m. Agenda: To review and evaluate grant applications. E:\FR\FM\18DEN1.SGM 18DEN1 64850 Federal Register / Vol. 83, No. 242 / Tuesday, December 18, 2018 / Notices Place: Hilton Washington DC/Rockville Hotel, 1750 Rockville Pike, Rockville, MD 20852. Contact Person: Clifford W. Schweinfest, Ph.D., Scientific Review Officer, Special Review Branch Division of Extramural Activities, National Cancer Institute, NIH, 9609 Medical Center Drive, Room 7W108, Bethesda, MD 20892–9750, 240–276–6343, schweinfestcw@mail.nih.gov. Name of Committee: National Cancer Institute, Special Emphasis Panel SEP–3 for Provocative Questions. Date: March 21, 2019. Time: 7:30 a.m. to 4:30 p.m. Agenda: To review and evaluate grant applications. Place: Hilton Washington DC/Rockville Hotel, 1750 Rockville Pike, Rockville, MD 20852. Contact Person: Hasan Siddiqui, Ph.D., Scientific Review Officer, Special Review Branch, Division of Extramural Activities, National Cancer Institute, NIH, 9609 Medical Center Drive, Room 7W240 Bethesda, MD 20892–9750, 240–276–5122, hasan.siddiqui@nih.gov. Name of Committee: National Cancer Institute Special Emphasis Panel TEP–9: Clonogenic High-Throughput Assay for AntiCancer Agents and Radiation Modulators. Date: March 28, 2019. Time: 10:00 a.m. to 3:00 p.m. Agenda: To review and evaluate contract proposals. Place: National Cancer Institute, Shady Grove, 9609 Medical Center Drive, Room 7W246 Rockville, MD 20850. Contact Person: Jun Fang, Ph.D., Scientific Review Officer, Research Technology and Contract Review Branch, Division of Extramural Activities, National Cancer Institute, NIH, 9609 Medical Center Drive, Room 7W260, Bethesda, MD, 20892–9750 240–276–5460, jfang@mail.nih.gov. (Catalogue of Federal Domestic Assistance Program Nos. 93.392, Cancer Construction; 93.393, Cancer Cause and Prevention Research; 93.394, Cancer Detection and Diagnosis Research; 93.395, Cancer Treatment Research; 93.396, Cancer Biology Research; 93.397, Cancer Centers Support; 93.398, Cancer Research Manpower; 93.399, Cancer Control, National Institutes of Health, HHS) Dated: December 11, 2018. Melanie J. Pantoja, Program Analyst, Office of Federal Advisory Committee Policy. amended, notice is hereby given of the following meeting. The meeting will be closed to the public in accordance with the provisions set forth in sections 552b(c)(4) and 552b(c)(6), Title 5 U.S.C., as amended. The grant applications and the discussions could disclose confidential trade secrets or commercial property such as patentable material, and personal information concerning individuals associated with the grant applications, the disclosure of which would constitute a clearly unwarranted invasion of personal privacy. Name of Committee: National Institute of Dental and Craniofacial Research Special Emphasis Panel; Dental Practice-Base Research Network. Date: January 7, 2019. Time: 1:00 p.m. to 5:00 p.m. Agenda: To review and evaluate grant applications. Place: NIDCR Conference Room, 651 Democracy One, 6701 Democracy Blvd., Bethesda, MD 20892. Contact Person: Guo He Zhang, MPH, Ph.D., Scientific Review Officer, Scientific Review Branch, Natl Institute of Dental and Craniofacial Research, National Institutes of Health, 6701 Democracy Boulevard, Suite 672, Bethesda, MD 20892, zhanggu@mail.nih.gov. (Catalogue of Federal Domestic Assistance Program Nos. 93.121, Oral Diseases and Disorders Research, National Institutes of Health, HHS) Dated: December 12, 2018. Natasha M. Copeland, Program Analyst, Office of Federal Advisory Committee Policy. [FR Doc. 2018–27277 Filed 12–17–18; 8:45 am] BILLING CODE 4140–01–P DEPARTMENT OF HEALTH AND HUMAN SERVICES National Institutes of Health Notice To Announce Webinar To Request Public Input on Upcoming Surgeon General’s Report on Oral Health AGENCY: [FR Doc. 2018–27178 Filed 12–17–18; 8:45 am] HHS. BILLING CODE 4140–01–P ACTION: National Institutes of Health, Notice. The National Institutes of Health (NIH), National Institute of Dental and Craniofacial Research (NIDCR), is announcing a webinar to provide background information pertaining to the commissioning of a new report on oral health by the Surgeon General and to obtain public input on the report. DATES: The webinar will be held on Thursday, January 10, 2019 from 12:00– SUMMARY: amozie on DSK3GDR082PROD with NOTICES DEPARTMENT OF HEALTH AND HUMAN SERVICES National Institutes of Health National Institute of Dental & Craniofacial Research Notice of Closed Meeting Pursuant to section 10(d) of the Federal Advisory Committee Act, as VerDate Sep<11>2014 00:45 Dec 18, 2018 Jkt 247001 PO 00000 Frm 00042 Fmt 4703 Sfmt 9990 12:30 p.m. EST. Written comments must be received before January 25, 2019. The webinar will be held by teleconference and online. Information is available at: www.nidcr.nih.gov/ SGReport-Oral-Health. You may submit written comments by: Email: NIDCRSGROH@nidcr.nih.gov; or Mail: Ms. Michelle Pitt, NIH/NIDCR, 31 Center Drive, Room 5B55, Bethesda, MD 20892. ADDRESSES: FOR FURTHER INFORMATION CONTACT: Bruce A. Dye, DDS, MPH, Dental Epidemiology Officer, Office of Science Policy and Analysis, NIH/NIDCR, 31 Center Drive, Room 5B55, Rockville, MD 20892. Email: bruce.dye@nih.gov. The webinar will update the public on the status of the new Surgeon General’s Report on Oral Health and provide an opportunity for the public to submit comments to help guide development of the report. Additional information about the upcoming report was published in a previous Federal Register Notice on July 27, 2018, 83 FR 35664. Interested persons or organizations are invited to submit written views on oral health, including the importance of poor oral health as a public health issue, contemporary issues affecting oral health, new knowledge that may transform the oral health of the nation, and future directions. NIDCR is also interested in receiving examples of partnerships or coalitions that have demonstrated improvement of oral health and wellbeing of individuals, families, or communities. Please note that comments received, including any supplemental material provided with the comments, are part of the public record and subject to public disclosure. Do not include any information in your comment or supporting materials that you consider confidential or inappropriate for public disclosure. NIDCR will carefully consider all comments submitted and may include relevant information in the upcoming Surgeon General’s Report on Oral Health. SUPPLEMENTARY INFORMATION: Dated: December 12, 2018. Lawrence A. Tabak, Deputy Director, National Institutes of Health. [FR Doc. 2018–27363 Filed 12–17–18; 8:45 am] BILLING CODE 4140–01–P E:\FR\FM\18DEN1.SGM 18DEN1

Agencies

[Federal Register Volume 83, Number 242 (Tuesday, December 18, 2018)]
[Notices]
[Pages 64848-64850]
From the Federal Register Online via the Government Publishing Office [www.gpo.gov]
[FR Doc No: 2018-27178]


-----------------------------------------------------------------------

DEPARTMENT OF HEALTH AND HUMAN SERVICES

National Institutes of Health


National Cancer Institute; Notice of Closed Meetings

    Pursuant to section 10(d) of the Federal Advisory Committee Act, as 
amended, notice is hereby given of the following meetings.
    The meetings will be closed to the public in accordance with the 
provisions set forth in sections 552b(c)(4) and 552b(c)(6), Title 5 
U.S.C., as amended. The grant applications and/or contract proposals 
and the discussions could disclose confidential trade secrets or 
commercial property such as patentable material, and personal 
information concerning individuals associated with grant and/or 
contract proposals applications, the

[[Page 64849]]

disclosure of which would constitute a clearly unwarranted invasion of 
personal privacy.

    Name of Committee: National Cancer Institute Special Emphasis 
Panel; Improving the Reach and Quality of Cancer Care in Rural 
Populations
    Date: January 18, 2019.
    Time: 7:30 a.m. to 5:00 p.m.
    Agenda: To review and evaluate grant applications.
    Place: Bethesda North Marriott Hotel & Conference Center, 5701 
Marinelli Road, North Bethesda, MD 20852.
    Contact Person: Clifford W. Schweinfest, Ph.D., Scientific 
Review Officer, Special Review Branch Division of Extramural 
Activities, National Cancer Institute, NIH, 9609 Medical Center 
Drive, Room 7W108 Bethesda, MD 20892-9750, 240-276-6343, 
schweinfestcw@mail.nih.gov.

    Name of Committee: National Cancer Institute, Special Emphasis 
Panel; NCI SPORE II (P50).
    Date: January 29-30, 2019.
    Time: 8:30 a.m. to 5:00 p.m.
    Agenda: To review and evaluate grant applications.
    Place: Gaithersburg Marriott Washingtonian Center, 9751 
Washingtonian Boulevard, Gaithersburg, MD 20878.
    Contact Person: Wlodek Lopaczynski, M.D., Ph.D., Scientific 
Review Officer, Office of the Director, Division of Extramural 
Activities, National Cancer Institute, NIH 9609 Medical Center 
Drive, Room 7W514, Bethesda, MD 20892-9750 240-276-6340, 
lopacw@mail.nih.gov.

    Name of Committee: National Cancer Institute Special Emphasis 
Panel; SEP-5: NCI Clinical and Translational R21 and Omnibus R03.
    Date: February 1, 2019.
    Time: 8:00 a.m. to 5:00 p.m.
    Agenda: To review and evaluate grant applications.
    Place: Hyatt Regency Bethesda, One Bethesda Metro Center, 7400 
Wisconsin Avenue Bethesda, MD 20814.
    Contact Person: Robert S. Coyne, Ph.D., Scientific Review 
Officer, Special Review Branch, Division of Extramural Activities, 
National Cancer Institute, NIH, 9609 Medical Center Drive, Room 
7W236, Bethesda, MD 20892-9750 240-276-5120, coyners@mail.nih.gov.

    Name of Committee: National Cancer Institute, Special Emphasis 
Panel; Quantitative Imaging Tools and Methods for Cancer Therapy 
Response Assessment.
    Date: February 1, 2019.
    Time: 11:00 a.m. to 3:30 p.m.
    Agenda: To review and evaluate grant applications.
    Place: National Cancer Institute, Shady Grove, 9609 Medical 
Center Drive, Room 7W640, Rockville, MD 20850 (Telephone Conference 
Call).
    Contact Person: Saejeong J. Kim, Ph.D., Scientific Review 
Officer, Special Review Branch, Division of Extramural Activities, 
National Cancer Institute, NIH, 9609 Medical Center Drive, Room 
7W640, Bethesda, MD 20892-9750, 240-276-5179, saejeong.kim@nih.gov.

    Name of Committee: National Cancer Institute Special Emphasis 
Panel; SEP-3: NCI Clinical and Translational R21 and Omnibus R03.
    Date: February 7-8, 2019.
    Time: 4:00 p.m. to 5:00 p.m.
    Agenda: To review and evaluate grant applications.
    Place: Bethesda North Marriott Hotel & Conference Center, 5701 
Marinelli Road, North Bethesda, MD 20852.
    Contact Person: Ombretta Salvucci, Ph.D., Scientific Review 
Officer, Special Review Branch, Division of Extramural Activities, 
National Cancer Institute, NIH, 9609 Medical Center Drive, Room 
7W264, Bethesda, MD 20892-9750, 240-276-7286, salvucco@mail.nih.gov.

    Name of Committee: National Cancer Institute Special Emphasis 
Panel; TEP-3: SBIR Contract Review.
    Date: February 13-14, 2019.
    Time: 10:00 a.m. to 2:00 p.m.
    Agenda: To review and evaluate contract proposals.
    Place: National Cancer Institute, Shady Grove, 9609 Medical 
Center Drive, Room 2W032, Rockville, MD 20850 (Telephone Conference 
Call).
    Contact Person: Eduardo E. Chufan, Ph.D., Scientific Review 
Officer, Research Technology and Contract Review Branch, Division of 
Extramural Activities, National Cancer Institute, NIH, 9609 Medical 
Center Drive, Room 7W254, Bethesda, MD 20892-9750, 240-276-7975, 
chufanee@mail.nih.gov.

    Name of Committee: National Cancer Institute Special Emphasis 
Panel; Biological Comparisons in Patient-Derived Models of Cancer.
    Date: February 22, 2019.
    Time: 1:00 p.m. to 3:00 p.m.
    Agenda: To review and evaluate grant applications.
    Place: National Cancer Institute, Shady Grove, 9609 Medical 
Center Drive, Room 7W236, Rockville, MD 20850 (Telephone Conference 
Call).
    Contact Person: Robert S. Coyne, Ph.D., Scientific Review 
Officer, Special Review Branch, Division of Extramural Activities, 
National Cancer Institute, NIH, 9609 Medical Center Drive, Room 
7W236, Bethesda, MD 20892-9750, 240-276-5120, coyners@mail.nih.gov.

    Name of Committee: National Cancer Institute Special Emphasis 
Panel; SEP-7: NCI Clinical and Translational R21 and Omnibus R03.
    Date: February 28, 2019.
    Time: 7:30 a.m. to 5:00 p.m.
    Agenda: To review and evaluate grant applications.
    Place: Bethesda North Marriott Hotel & Conference Center, 5701 
Marinelli Road, North Bethesda, MD 20852.
    Contact Person: Saejeong J. Kim, Ph.D., Scientific Review 
Officer, Special Review Branch, Division of Extramural Activities, 
National Cancer Institute, NIH, 9609 Medical Center Drive, Room 
7W640, Bethesda, MD 20892-9750, 240-276-2432, saejeong.kim@nih.gov.

    Name of Committee: National Cancer Institute Special Emphasis 
Panel; NCORP Research Bases.
    Date: March 5, 2019.
    Time: 8:00 a.m. to 5:00 p.m.
    Agenda: To review and evaluate grant applications.
    Place: National Cancer Institute, Shady Grove, 9609 Medical 
Center Drive, Room 7W032/034, Rockville, MD 20850.
    Contact Person: Michael B. Small, Ph.D., Scientific Review 
Officer, Program and Review Extramural Staff Training Office, 
Division of Extramural Activities, National Cancer Institute, NIH, 
9609 Medical Center Drive, Room 7W412, Bethesda, MD 20892-9750, 240-
276-6384, smallm@mail.nih.gov.

    Name of Committee: National Cancer Institute Special Emphasis 
Panel; Community Oncology Research Program--Community Sites.
    Date: March 7-8, 2019.
    Time: 8:00 a.m. to 5:00 p.m.
    Agenda: To review and evaluate grant applications.
    Place: National Cancer Institute, Shady Grove, 9609 Medical 
Center Drive, Room TE406, Rockville, MD 20850.
    Contact Person: Timothy C. Meeker, M.D., Ph.D., Scientific 
Review Officer, Resources and Training Review Branch, Division of 
Extramural Activities, National Cancer Institute, NIH, 9609 Medical 
Center Drive, Room 7W606, Bethesda, MD 20892-9750, 240-276-6464, 
meekert@mail.nih.gov.

    Name of Committee: National Cancer Institute Special Emphasis 
Panel; SEP-1 for Provocative Questions.
    Date: March 7, 2019.
    Time: 8:00 a.m. to 5:00 p.m.
    Agenda: To review and evaluate grant applications.
    Place: Bethesda North Marriott Hotel & Conference Center, 5701 
Marinelli Road, North Bethesda, MD 20852.


    Contact Person: Hasan Siddiqui, Ph.D. , Scientific Review 
Officer, Special Review Branch, Division of Extramural Activities, 
National Cancer Institute, NIH, 9609 Medical Center Drive, Room 
7W240, Bethesda, MD 20892-9750, 240-276-5122, 
hasan.siddiqui@nih.gov.

    Name of Committee: National Cancer Institute Special Emphasis 
Panel; SEP-6: NCI Clinical and Translational R21 and Omnibus R03.
    Date: March 7-8, 2019.
    Time: 5:00 p.m. to 4:00 p.m.
    Agenda: To review and evaluate grant applications.
    Place: Bethesda North Marriott Hotel & Conference Center, 5701 
Marinelli Road, North Bethesda, MD 20852.
    Contact Person: Eduardo E. Chufan, Ph.D., Scientific Review 
Officer, Research Technology and Contract Review Branch, Division of 
Extramural Activities, National Cancer Institute, NIH, 9609 Medical 
Center Drive, Room 7W254, Bethesda, MD 20892-9750, 240-276-7975, 
chufanee@mail.nih.gov.

    Name of Committee: National Cancer Institute Special Emphasis 
Panel SEP-4 for Provocative Questions.
    Date: March 14-15, 2019.
    Time: 6:00 p.m. to 3:00 p.m.
    Agenda: To review and evaluate grant applications.

[[Page 64850]]

    Place: Hilton Washington DC/Rockville Hotel, 1750 Rockville 
Pike, Rockville, MD 20852.
    Contact Person: Clifford W. Schweinfest, Ph.D., Scientific 
Review Officer, Special Review Branch Division of Extramural 
Activities, National Cancer Institute, NIH, 9609 Medical Center 
Drive, Room 7W108, Bethesda, MD 20892-9750, 240-276-6343, 
schweinfestcw@mail.nih.gov.

    Name of Committee: National Cancer Institute, Special Emphasis 
Panel SEP-3 for Provocative Questions.
    Date: March 21, 2019.
    Time: 7:30 a.m. to 4:30 p.m.
    Agenda: To review and evaluate grant applications.
    Place: Hilton Washington DC/Rockville Hotel, 1750 Rockville 
Pike, Rockville, MD 20852.
    Contact Person: Hasan Siddiqui, Ph.D., Scientific Review 
Officer, Special Review Branch, Division of Extramural Activities, 
National Cancer Institute, NIH, 9609 Medical Center Drive, Room 
7W240 Bethesda, MD 20892-9750, 240-276-5122, hasan.siddiqui@nih.gov.

    Name of Committee: National Cancer Institute Special Emphasis 
Panel TEP-9: Clonogenic High-Throughput Assay for Anti-Cancer Agents 
and Radiation Modulators.
    Date: March 28, 2019.
    Time: 10:00 a.m. to 3:00 p.m.
    Agenda: To review and evaluate contract proposals.
    Place: National Cancer Institute, Shady Grove, 9609 Medical 
Center Drive, Room 7W246 Rockville, MD 20850.
    Contact Person: Jun Fang, Ph.D., Scientific Review Officer, 
Research Technology and Contract Review Branch, Division of 
Extramural Activities, National Cancer Institute, NIH, 9609 Medical 
Center Drive, Room 7W260, Bethesda, MD, 20892-9750 240-276-5460, 
jfang@mail.nih.gov.

(Catalogue of Federal Domestic Assistance Program Nos. 93.392, 
Cancer Construction; 93.393, Cancer Cause and Prevention Research; 
93.394, Cancer Detection and Diagnosis Research; 93.395, Cancer 
Treatment Research; 93.396, Cancer Biology Research; 93.397, Cancer 
Centers Support; 93.398, Cancer Research Manpower; 93.399, Cancer 
Control, National Institutes of Health, HHS)


    Dated: December 11, 2018.
Melanie J. Pantoja,
Program Analyst, Office of Federal Advisory Committee Policy.
[FR Doc. 2018-27178 Filed 12-17-18; 8:45 am]
 BILLING CODE 4140-01-P
This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.